GenScript
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,700 employees and has served more than 200,000 customers across over 100 countries and regions.
Neoantigen Peptide Synthesis Service
GenScript’s Neoantigen Peptide Synthesis Service supports everything from functional screening of neoantigen candidates for TCR therapy to clinical stage vaccine immunogenicity testing.
GenScript saRNA: Amplify Expression, Accelerate Discovery
Unlock prolonged and enhanced gene expression with GenScript’s self-amplifying RNA (saRNA) solutions. . Our ready-to-use saRNA is ideal for vaccine development, gene therapy, and advanced research app...
GenCRISPR Synthetic sgRNA
Accelerate precision gene editing with GenScript's customized synthetic sgRNA, up to 266 nt in length.
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,700 employees and has served more than 200,000 customers across over 100 countries and regions.